The study consisted of two parts, part 1 and part 2. The mean age in part 1 (6 patients) was 28.7 (4.3) years (mean [SD]; hereafter the same), and the mean BMI was 20.95 (1.14) kg/m2. The mean age in part 2 (6 patients) was 32.5 (8.7) years and the mean BMI was 21.30 (1.83) kg/m2.
Of the 39 subjects who gave informed consent, 6 participated in part 1 and 6 participated in part 2; a total of 12 subjects received oral gelatin loading. All subjects completed the study, and there were no withdrawals after gelatin loading.
/
パート1、パート2のいずれのパートでも有害事象は認められなかった。
No adverse event was reported in either part 1 or part 2.
Cmax and AUC0-t of plasma hydroxyproline increased in proportion to gelatine loading dose, and tmax and t1/2 did not vary significantly due to differences in the gelatin loading dose. No adverse events and no significant changes in laboratory values or vital signs was reported.
Oral loading of healthy adult men with gelatin resulted in a proportional increase in plasma hydroxyproline concentration with gelatin loading dose. The safety and tolerability of oral gelatine loading was clinically acceptable.
Presence of a psychological, gastrointestinal, hepatic, renal, respiratory, endocrine, hematological, immune, neurological, cardiovascular disease or a congenital metabolic abnormality or other anomaly that may affect this study